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Abstract  
 
The gadolinium-based contrast agent (GdBCA) Omniscan activates human macrophages 
through TLR4 and TLR7 signaling.  To explore the mechanisms responsible we compared 
the ability of linear and macrocyclic GdBCA to induce a type I interferon signature and a 
proinflammatory/profibrotic phenotype in normal human monocytes in vitro. Expression of 
genes associated with type I interferon signaling and inflammation, and production of their 
corresponding proteins were determined. Both linear and macrocyclic GdBCA stimulated 
expression of multiple type I interferon regulated genes and the expression of numerous 
chemokines, cytokines and growth factors in normal human peripheral blood monocytes.  
There was no correlation between the magnitude of the measured response and the Gd 
chelate used. To explore the mechanisms responsible for GdBCA induction of fibrosis in 
Nephrogenic Systemic Fibrosis (NSF) in vitro, normal human dermal fibroblasts were 
incubated with GdBCA-treated monocyte culture supernatants and the effects on profibrotic 
gene expression were examined.    Supernatants from monocytes exposed to all GdBCA 
stimulated types I and III collagen, fibronectin and -SMA expression in normal dermal 
fibroblasts. The results indicate that the monocyte activation induced by GdBCA may be 
the initial step in the development of GdBCA associated fibrosis in NSF.  
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Introduction  
 Nephrogenic Systemic Fibrosis (NSF) is a systemic fibrosing disorder occurring in 
patients with chronic kidney disease (CKD) characterized by progressive fibrosis of skin, 
periarticular tissues, striated muscles and various internal organs (1-4).  Histopathological 
studies of affected NSF skin demonstrate severe dermal and subdermal fibrosis, prominent 
mucin deposition, accumulation of activated fibroblasts and macrophages, and strikingly 
increased in situ expression of transforming growth factor beta (TGF-)(3). Although the 
exact mechanisms responsible for NSF development are not known the majority of reported 
cases occurred following exposure to high doses of Gd based contrast agents (GdBCA) in 
the context of renal insufficiency (5-8). Gd accumulation in CKD patient tissues is thought 
to be the primary event in NSF pathogenesis. Indeed, numerous studies have described Gd 
deposition in affected tissues from NSF patients (9-11).     
 Two models that differ in the nature of the bioactive form of Gd associated with 
NSF occurrence in CKD individuals have been proposed (12-16). The transmetallation 
model posits that GdBCA accumulate in the extravascular space and tissues where 
endogenous free cations such as Zn2+, Ca2+, Cu2+, or Fe2+ displace Gd3+ from the chelate 
complex (12-15). The Gd3+ released from the chelate complex can induce activation of 
various profibrotic molecular pathways in one or more of the cell types present in fibrotic 
NSF lesions, such as macrophages, fibroblasts and fibrocytes. According to this model, less 
thermodynamically stable linear GdBCA are more prone to undergo transmetallation 
thereby initiating the fibrotic process leading to NSF. The second model, the chelate model, 
proposes that intact Gd chelate complexes, rather than transmetallated Gd3+, are the 
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bioactive agent triggering the NSF fibrotic process (16). This model suggests that certain 
intrinsic property(s) of the intact Gd chelate complex is(are) responsible for the 
disproportionately greater association of linear GdBCA with NSF development compared 
to macrocyclic GdBCA based on exposure rates to these classes of agents. 
 Activated macrophage infiltration into affected NSF skin and visceral tissues (3) 
and the induction of a proinflammatory/profibrotic phenotype in normal human peripheral 
monocytes and macrophages by the linear contrast agents Omniscan and Gd-DTPA have 
been previously described (17,18). Recently, it has been reported that Omniscan stimulation 
of production of proinflammatory/profibrotic cytokines, chemokines and growth factors is 
mediated by TLR4 and TLR7 in normal differentiated human macrophages (19). Numerous 
other studies have demonstrated that GdBCA can induce profibrotic responses in normal 
and NSF fibroblasts as well as in skin organ cultures (20-23). However, the induction of a 
Type I interferon signature, and a detailed comparison of proinflammatory and profibrotic 
effects of various linear and macrocyclic GdBCA have not been performed. Thus, the 
purpose of the present study was to compare the ability of four different linear GdBCA and 
two different macrocyclic GdBCA to induce a Type I interferon signature and the 
expression of a proinflammatory/profibrotic phenotype in normal human monocytes in 
vitro. Furthermore, the effects of supernatants from these cells on cultured normal human 
dermal fibroblasts were examined to explore the mechanisms that might be responsible for 
the differential association of various GdBCA agents with NSF development.    
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Experimental 
Gd compounds.  Dotarem® (Guerbet LLC, Bloomington, IL) , MultiHance® (Bracco 
Diagnostics, Milan, IT), ProHance® (Bracco Diagnostics, Milan, IT), OptiMark® 
(Mallinckrodt Inc/Covidien, Hazelwood, IN), were supplied as sterile, aqueous solutions 
each containing 500 mM of the Gd chelate.  Omniscan® and gadodiamide (provided by GE 
Healthcare, Chalfont St. Giles, UK) were supplied as sterile, aqueous solutions each 
containing 287 mg/ml (500 mM) gadodiamide.  The Omniscan® solution contained an 
additional 12 mg/ml (25 mM) caldiamide sodium in water.  Caldiamide (GE Healthcare) 
was supplied as a sterile aqueous solution containing 12 mg/ml (25 mM) caldiamide 
sodium in water.  Gd-EDTA (GE Healthcare) was supplied as a sterile aqueous solution 
containing 250 mM Gd-EDTA in water.  Gd-Citrate (250 µM) was prepared by mixing 1 
mL of 250 µM gadolinium chloride and 1 mL of 500 µM sodium citrate solutions at pH 7.4 
(24).  Gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA; Sigma-Aldrich. St. 
Louis, MO), the Gd chelate used in Magnevist®, was dissolved in sterile PBS solution at 
0.5M concentration.  The reagents employed for all the studies were tested and verified by 
the manufacturer to be free from endotoxin contamination.  The absence of endotoxin 
contamination was further confirmed in our laboratories utilizing the Etoxate Assay 
(Sigma-Aldrich) according to the manufacturer’s instructions. 
Monocyte Isolation.  Leukoreduction filters from three different normal donors were 
obtained from the Thomas Jefferson University Hospital Blood Bank following 
Institutional Review Board approval.  Human peripheral blood mononuclear cells (PBMC) 
were isolated from the filters by Ficoll-Hypaque gradient centrifugation (Amersham 
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Pharmacia Biotech, Piscataway, NJ) and enriched for monocytes by adherence to plastic 
culture dishes for 2 h as described (17,25).   
Treatment of monocytes with Gd compounds. Equal numbers of monocytes were plated 
in 60 mm plastic culture dishes in RPMI 1640 media supplemented with 25 mM HEPES, 
L-glutamine and 10% FBS. Lipopolysaccharide (LPS;1 μg/ml) was the positive control and 
sterile saline was the negative control. Cells were exposed for 12 h or 24 h to 5 mM of each 
of the six GdBCA or to 250 µM caldiamide which corresponds to the amount present in the 
Omniscan® preparation.  Total RNA was isolated from the cells exposed to GdBCA for 12 
h as previously described (17,18) and supernatants from each sample were collected and 
stored at -20oC until used.   
Enzyme-linked immunosorbent assay. SearchLight ELISA proteome array analyses 
(Pierce Biotechnology, Woburn, MA) were performed as described previously (17,18) to 
quantitate the levels of IL-4, IL-6, IL-13, IFN-, TGF-β, and VEGF in supernatants from 
monocytes exposed to the Gd compounds for 24 h.  Briefly, samples were diluted 1:2, 1:50, 
and 1:1,000 and then incubated for 1 h on the array plates which had been prespotted with 
capture antibodies specific for each protein.  Plates were decanted and washed 3 times with 
PBS before addition of a mixture of biotinylated detection antibodies to each well. 
Following incubation with detection antibodies for 30 min, plates were washed 3 times and 
incubated for 30 min with streptavidin–horseradish peroxidase. Plates were again washed 
and SuperSignal Femto chemiluminescent substrate was added. The plates were 
immediately imaged using the SearchLight imaging system and data were analyzed using 
ArrayVision software. 
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Real-time polymerase chain reaction (PCR).  Monocyte and fibroblast transcript levels 
were quantified using SYBR Green real time PCR, as previously described (17,18). Primers 
were designed using Primer Express software (Applied Biosystems, Foster City, CA) and 
validated for specificity The primers employed are displayed in Supplemental Table 1. The 
differences in the number of mRNA copies in each PCR were corrected for human β-actin 
endogenous control transcript levels; levels in control experiments were set at 100 and all 
other values expressed as multiples of control values. 
Treatment of cultured fibroblasts with conditioned media from peripheral blood 
monocytes exposed to Gd compounds.  Two normal human dermal fibroblast cell lines 
(passages 4-10) from the Scleroderma Center Tissue Bank, Thomas Jefferson University, 
were cultured in Dulbecco’s modified Eagle’s (MEM) medium supplemented with 10% 
fetal bovine serum, antibiotics, 50 mM HEPES, and glutamine until confluent.   
For experiments, the cells were cultured in complete medium in 6-well plastic plates until 
confluence. Following preincubation for 24 h with 40 μg/ml ascorbic acid (Sigma-Aldrich) 
to optimize collagen production, fibroblasts were incubated for 24 h with conditioned 
media from Gd-exposed peripheral blood monocytes at a 1:2 dilution.  Fibroblasts were 
then were harvested with trypsin-EDTA, washed with PBS, and then processed for RNA 
extraction using the RNeasy kit (Qiagen, Valencia, CA) as described previously (17,18).   
Statistical analysis.  Real-time PCR values reflect the mean and standard deviation of three 
separate experiments each performed in triplicate with each of the three samples of normal 
human macrophages.  The statistical significance of the real-time PCR data was assessed by 
Student’s two-tailed t test.  P values less than 0.05 were considered statistically significant.   
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Results 
Effects of Gd compounds on cytokine and growth factor gene expression levels 
in normal human monocytes.  Expression levels of profibrotic/proinflammatory cytokines 
in normal human monocytes in response to 12 h exposure to Gd-containing agents were 
analyzed by real time PCR. IL-6 and IL-13 were markedly increased in response to all Gd 
compounds whereas VEGF was increased by all Gd compounds except MultiHance and 
OptiMARK (Figure 1).  IL-4 was increased by all Gd compounds except Gd-DTPA, 
MultiHance and OptiMARK whereas TGF was increased only in response to Omniscan, 
gadodiamide, Gd-EDTA and Gd-Citrate.  IFN-, however, was increased only in response 
to Gd-DTPA, Dotarem and ProHance. No correlation between the level of induction of 
expression of various genes encoding the proinflammatory/profibrotic cytokines and 
growth factors and the structure of the GdBCA chelate molecule or the non-chelated Gd 
compound was observed.  Exposure of monocytes to caldiamide had no effect on the 
expression level of any gene measured. 
Effects of Gd compounds on chemokine gene expression levels by normal 
human monocytes.  Expression levels of chemokine genes in normal human monocytes in 
response to 12 h exposure to Gd-containing agents were analyzed by real time PCR. 
CXCL9 and CXCL12 were markedly increased in response to all Gd compounds whereas 
CCL2 was increased by all Gd compounds except Gd-DTPA and CCL8 was increased by 
all Gd compounds except OptiMARK (Figure 2).  CXCL11 was increased by all Gd 
compounds except MultiHance and Dotarem whereas CXCL10 was increased only in 
response to Gd-DTPA, Omniscan, gadodiamide, Gd-EDTA and Gd-Citrate.  As with 
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expression levels of cytokines and growth factors, no correlation between the level of 
response attained and the structure of the chelate molecule of the GdBCA was observed. 
 Effects of Gd compounds on normal human monocyte production of 
proinflammatory/profibrotic cytokines and chemokines. To assess whether the effects 
observed at the gene expression level were also reflected at the protein level, the amounts 
of cytokines and growth factors present in culture supernatants isolated from normal human 
monocytes incubated for 24 h with the Gd compounds were assayed by SearchLight 
proteome multiplex arrays (Figure 3). The levels of IL4, IL13, and TGF produced were 
significantly elevated by all of the GdBCA tested, regardless of the chelate class (Figure 
3), and all agents except for OptiMARK induced increased VEGF levels whereas only 
Omniscan, gadodiamide and ProHance significantly induced increased production of IL-6. 
Omniscan and gadodiamide treated cells produced the highest levels of IL-4, IL-6, and IL-
13, whereas, Omniscan, gadodiamide and MultiHance produced the highest levels of 
VEGF. 
Conditioned media from Gd-stimulated normal human monocytes induce a 
profibrotic phenotype in normal human dermal fibroblasts. Fibroblasts cultured with 
supernatants from monocytes that had been exposed to linear and macrocyclic GdBCA or 
to nonchelated Gd compounds displayed increased expression of type I and type III human 
collagen (COL1A and COL3A) respectively. All monocyte supernatants caused collagen 
gene expression stimulation with similar efficacy (Figure 4). Similarly, -smooth muscle 
actin (-SMA) expression, a marker of myofibroblast activation, and fibronectin (FN1) 
expression were upregulated by all of the GdBCA, although supernatants from cells 
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exposed to the linear chelate GdBCA showed a slightly greater level of upregulation of -
SMA expression compared to those induced by macrocyclic GdBCA.  In contrast, 
supernatants from monocytes exposed to caldiamide alone did not affect expression of any 
of the genes examined in the cultured fibroblasts. 
Effects of Gd compounds on expression levels of type I inteferons and of genes 
involved in induction of NFB by normal human monocytes.  Expression levels of type 
I interferons (IFN-α and IFN-) and of the NFB activator genes, Interferon Regulatory 
Factor 1 (IRF1), IRF4, IRF9 and X-linked Inhibitor of Apoptosis (XIAP) were analyzed in 
normal human monocytes following 12 h exposure to Gd-containing agents. All linear 
chelates and non-chelated Gd compounds induced striking increases in the expression of all 
6 genes (Figure 5).  In contrast, Dotarem induced increased expression of IFN-α, IFN-, 
IRF4 and IRF9 but not of IRF1 or XIAP and ProHance increased expression of only IFN-α, 
IFN- and IRF9.   
Effects of Gd compounds on gene expression levels of interferon-responsive 
genes by normal human monocytes.  Analysis of expression levels of interferon-
responsive genes in normal human monocytes in response to 12 h exposure to Gd-
containing agents were analyzed next. Expression of CCL20, Interferon Inducible 44-like 
(IFI44L), Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1), IL8, IL18 and 
Immunoresponsive gene 1 (IRG1) were all markedly increased in response to all GdBCA 
(Figure 6).  No correlation was observed between the level of response attained and the 
structure of the chelate molecule of the GdBCA with all linear and macrocyclic GdBCA. 
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We also found that all non-chelated Gd compounds induced expression of all interferon-
responsive genes. 
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Discussion 
Exposure to GdBCA is a crucial event in NSF pathogenesis but the mechanisms that 
trigger this severe fibrotic disease are poorly understood. Multiple, non-mutually exclusive 
hypotheses to explain the roles of a variety of molecular pathways and possible cofactors in 
NSF pathogenesis have been proposed (reviewed in 12-16, 26, 27).  One area of debate 
concerns the form of the active Gd molecule. The transmetallation hypothesis proposes that 
free Gd3+ is the active form (12-15) whereas the chelate hypothesis posits the intact Gd 
chelate molecule instead (16). The present study was designed to compare the relative 
abilities of linear and macrocyclic GdBCA to induce a proinflammatory/profibrotic 
phenotype in normal human monocytes.  A second goal of the studies described was to 
examine the ability of the linear and macrocyclic GcBCA to affect expression levels of type 
I IFNs and type I IFN responsive genes as well as genes involved in NFB expression and 
NFB-mediated transcriptional activation. These studies were carried out in order to 
provide a mechanistic link between the previously described GdBCA signaling through 
TLR4 and TLR7 (19) and the induction of the profibrotic/proinflammatory phenotype 
responsible for NSF development. 
The results demonstrate that both classes of GdBCA as well as non-chelated Gd 
compounds induce in normal human monocytes the expression and secretion of numerous 
cytokines, chemokines and growth factors generally recognized as important mediators of 
the initiation and/or progression of the fibrotic process. Further, culture supernatants 
isolated from monocytes exposed to either linear or macrocyclic agents or to non-chelated 
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Gd compounds were shown to stimulate type I and type III collagens and α-SMA and FN1 
expression in normal human dermal fibroblasts.  While we recognize that HEPES buffer 
may negatively affect B-lymphocyte DNA replication, several studies have found that this 
effect is observed only in the absence of CO2 (28) and that in the presence of CO2 HEPES 
offers greater buffering capacity and ensures better cell survival and stimulation of cellular 
proliferation (29).  Indeed, in a previous study we observed comparable levels of 
stimulation of gene expression by GdBCA in human macrophages cultured in the presence 
of HEPES to the results described here in human lymphocytes (19). The changes in 
expression of numerous proinflammatory/profibrotic chemokines, cytokines and growth 
factors and of type I interferon responsive genes were consistent in three separate 
experiments utilizing monocytes derived from three different normal individuals. However, 
the magnitude of the observed effects was variable among the cells from the three 
individuals, possibly owing to genetic heterogeneity and variability in the sensitivity of 
monocytes from different donors to the activating stimuli. These observations are consistent 
with epidemiological studies showing that NSF development occurs infrequently even 
among the large population of renal insufficiency patients exposed to GdBCA. 
There was no correlation between the induction of proinflammatory/profibrotic 
gene expression in normal human monocytes with the dynamic stability of the GdBCA as 
would be expected if the active agent was free Gd3+. While some free Gd3+ release cannot 
be entirely ruled out for ProHance, the thermodynamic stability of Dotarem at the acidic pH 
levels found in macrophage lysosomal compartments is ~338 h (27). Therefore, if free Gd3+ 
is required for the induction of profibrotic molecular pathways as proposed in the 
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transmetallation hypothesis, then the macrocyclic agents should have had minimal or no 
detectable effects on cytokine and growth factor expression. Thus, the greater ability of 
certain GcBCA to induce NSF cannot be explained simply to their enhanced susceptibility 
to undergo transmetallation. It seems more likely that a unique characteristic of certain 
linear GdBCA or of gadodiamide in particular, such as its shape, molecular pattern, or 
molecular surface reactivity is responsible for the disproportionately high frequency of NSF 
cases associated with their use.  
It has recently been reported that Omniscan and gadodiamide induce TLR4 and 
TLR7-dependent expression of profibrotic/proinflammatory cytokines and growth factors 
in normal human differentiated macrophages (19). The results described here demonstrate 
that all Gd compounds examined were capable of inducing expression of genes associated 
with TLR signaling, including XIAP, which activates NFB expression in response to 
TGF signaling (30), and of IRF1, IRF4 and IRF9 which are components of downstream 
intracellular signaling complexes mediating NFB target gene regulation and induction of 
type I IFN expression (31-34).  Interestingly, exposure to all Gd compounds tested resulted 
in a striking induction of the expression of type I interferon responsive genes CCL20, 
IFI44L, IFIT, IL8, IL18 and IRG1. These observations are consistent with the notion that 
GdBCA molecular pattern recognition by the TLR as well as a direct effect of free Gd3+ 
participate in NSF pathogenesis. 
These results, therefore, suggest the establishment of a signaling pathway in which 
GdBCA as well as non-chelated Gd compounds signal through TLR4 and TLR7, inducing 
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expression of XIAP and IRF genes that mediate NFB activation.  NFB activation and 
signaling, in turn, induce the expression of type I interferon responsive genes that mediate 
the establishment of a proinflammatory/profibrotic phenotype characterized by the 
expression and production of cytokines, chemokines and growth factors capable of 
triggering the activation of quiescent fibroblasts into myofibroblasts.  This putative 
pathway is illustrated in Figure 7. These results are of relevance to other fibrotic disorders 
such as Systemic Sclerosis (SSc) in which activation of a type I interferon pathway has 
been reported (35-41).   
 In conclusion, the results described here demonstrate that GdBCA, regardless of 
chelate class and thermodynamic stability, induce in normal human monocytes remarkably 
potent expression of numerous genes encoding well-characterized 
profibrotic/proinflammatory chemokines, cytokines and growth factors and of type I 
interferons and interferon-responsive genes resulting in their increased production and 
release. Furthermore, conditioned medium from monocytes exposed to the different Gd-
containing compounds caused a potent stimulation of expression of the profibrotic markers 
types I and III collagen, fibronectin and -SMA in normal human dermal fibroblasts. The 
observations that both linear and macrocylic classes of Gd chelates as well as the non-
chelated Gd-containing compounds induce these potent cellular phenotypic and gene 
expression changes in normal human macrophages indicate that GdBCA thermodynamic 
stability is not likely to be the primary factor influencing the relative activity of these 
compounds in the induction of NSF.  
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Figure Legends 
 
 
Figure 1.  Effect of non-ionic and ionic linear and macrocyclic GdBCA on the 
expression levels of various genes encoding profibrotic/proinflammatory cytokines 
and growth factors in normal human monocytes. Values represent the mean (+/- SD) 
expression levels of three replicates of three separate experiments with monocytes obtained 
from three different normal individuals exposed to the Gd compounds for 12 h.  C(t) values 
for cytokines were normalized with β-actin. The saline control levels were arbitrarily set at 
100% expression at each time point. Values for other samples are expressed relative to the 
saline control.  Expression levels of (A) IL4, (B) IL6, (C) IL13, (D) IFN, (E) TGF, and 
(F) VEGF transcripts are displayed. Statistical significance of changes in cytokine and 
growth factor expression as determined by Student’s T test comparing each Gd compound 
to the saline control appears above the corresponding bar. *: p<0.05; **: p < 0.01; ***: 
p<0.001.   Caldiamide did not induce a significant effect for any cytokine or growth factor. 
 
Figure 2.  Effect of non-ionic and ionic linear and macrocyclic GdBCA on the 
expression levels of various chemokine genes in normal human monocytes. Values 
represent the mean (+/- SD) expression levels of three replicates of three separate 
experiments with monocytes obtained from three different normal individuals exposed to 
the Gd compounds for 12 h.  C(t) values for cytokines were normalized with β-actin. The 
saline control levels were arbitrarily set at 100% expression at each time point. Values for 
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other samples are expressed relative to the saline control.  Expression levels of (A) CCL2, 
(B) CCL8, (C) CXCL9, (D) CXCL10, (E) CXCL11, and (F) CXCL12 transcripts are 
displayed. Statistical significance of changes in chemokine expression as determined by 
Student’s T test comparing each Gd compound to the saline control appears above the 
corresponding bar. *: p<0.05; **: p < 0.01; ***: p<0.001.   Caldiamide did not induce a 
significant effect for any cytokine or growth factor. 
 
Figure 3. Quantitative measurement of various cytokines and growth factors present 
in the culture media of Gd-compound-exposed normal human monocytes employing 
multiplex proteome array analyses. Cells were incubated with either saline, 5 mM Gd-
DTPA, MultiHance, Omniscan, gadodiamide, Dotarem or ProHance, or 2.5 mM caldiamide 
for 24 h and the culture media was assayed. Values are expressed in pg/ml and represent 
the mean (+/-) value of values obtained from duplicate results of pooled samples of 3 
individuals at 3 dilutions: 1:2, 1:50 and 1:1000. Statistical significance of changes in 
cytokine and growth factor expression as determined by Student’s T test comparing each 
Gd compound to the saline control appears above the corresponding bar. *: p<0.05; **: p < 
0.01; ***: p<0.001.   Caldiamide did not induce a significant effect for any cytokine or 
growth factor. 
 
Figure 4.  Effects of supernatants from monocytes exposed to Gd compounds on 
expression of types I and III collagen, fibronectin and -SMA in normal dermal 
human fibroblasts.  Fibroblasts were incubated for 24 h in media containing a 1:2 dilution 
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of culture supernatants isolated from monocytes exposed to Gd compounds for 12 h. 
Expression levels of (A) COL1A1, (B) COL3A1, (C) FN1 and (D) α-SMA transcripts 
determined by real time PCR. The results shown are representative of three separate 
experiments, each performed in triplicate. The saline control levels were arbitrarily set at 
100%. Values for the samples are expressed as the mean (+/- SD) percent increase over the 
saline control value. Statistical significance of changes in cytokine and growth factor 
expression as determined by Student’s T test comparing each Gd compound to the saline 
control appears above the corresponding bar. *: p<0.05; **: p < 0.01; ***: p<0.001.   
Supernatants from monocytes exposed to caldiamide did not induce a significant effect on 
fibroblast gene expression.  
 
Figure 5.  Effects of Gd compounds on expression of XIAP and IRF family genes in 
normal human monocytes.  Values represent the mean (+/- SD) expression levels of three 
replicates of three separate experiments with monocytes obtained from three different 
normal individuals.  C(t) values for cytokines were normalized with β-actin. The saline 
control levels were arbitrarily set at 100% expression at each time point. Values for other 
samples are expressed relative to the saline control.  Expression levels of (A) IRF1, (B) 
IRF4, (C) IRF9, and (D) XIAP transcripts are displayed. Statistical significance of changes 
in chemokine expression as determined by Student’s T test comparing each Gd compound 
to the saline control appears above the corresponding bar. *: p<0.05; **: p < 0.01; ***: 
p<0.001.   Caldiamide did not induce a significant effect. 
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Figure 6.  Effects of Gd compounds on expression of type I interferon responsive 
genes in normal human monocytes.  Values represent the mean (+/- SD) expression 
levels of three replicates of three separate experiments with monocytes obtained from three 
different normal individuals.  C(t) values for cytokines were normalized with β-actin. The 
saline control levels were arbitrarily set at 100% expression at each time point. Values for 
other samples are expressed relative to the saline control.  Expression levels of (A) CCL20, 
(B) IFI44L, (C) IFIT1, (D) IL8, (E) IL18, and (F) IRG1 transcripts are displayed. 
Statistical significance of changes in chemokine expression as determined by Student’s T 
test comparing each Gd compound to the saline control appears above the corresponding 
bar. *: p<0.05; **: p < 0.01; ***: p<0.001.   Caldiamide did not induce a significant effect. 
 
Figure 7.  Pathways mediating GdBCA induction of proinflammatory/profibrotic 
phenotype in normal human macrophages. Cellular recognition of either free Gd3+ 
(transmetallation model) or of the intact chelated GdBCA (chelate model) is mediated 
through TLR4 and TLR7 signaling.  The signaling events  result in upregulation of XIAP 
and IRF genes and activation of NFB which cooperate to upregulate type I interferons, 
that in turn activate type I interferon signature genes (ISGs) resulting in production of 
proinflammatory and profibrotic chemokines, cytokines and growth factors.  These factors 
are secreted by activated macrophages and can then act to promote the transdifferentiation 
of quiescent fibroblasts to activated myofibroblasts, characterized by initiation of α-SMA 
expression and  in dysregulated and sustained extracellular matrix production leading to 
tissue fibrosis. Figure modified from (19). 
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